Ontology highlight
ABSTRACT: Background
The drug interaction between warfarin and rifampicin is widely known, but there are still some difficulties in managing the combination of the two drugs.Case summary
A patient with brucellosis received strict monitoring from a Chinese pharmacist team during combination of warfarin and rifampicin. The dose of warfarin was increased to 350% in 3 mo before reaching the lower international normalized ratio treatment window. No obvious adverse reaction occurred during the drug-adjustment period. This is the first case report of long-term combined use of rifampicin and warfarin in patients with brucellosis and valve replacement in China based on the Chinese lower warfarin dose and international normalized ratio range.Conclusion
Anticoagulation for valve replacement in Chinese patients differs from that in other races. Establishment of a pharmacist clinic provides vital assistance in warfarin dose adjustment.
SUBMITTER: Hu YN
PROVIDER: S-EPMC7896655 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Hu Ya-Ni YN Zhou Bo-Ting BT Yang Hua-Rong HR Peng Qi-Lin QL Gu Xu-Rui XR Sun Shu-Sen SS
World journal of clinical cases 20210201 5
<h4>Background</h4>The drug interaction between warfarin and rifampicin is widely known, but there are still some difficulties in managing the combination of the two drugs.<h4>Case summary</h4>A patient with brucellosis received strict monitoring from a Chinese pharmacist team during combination of warfarin and rifampicin. The dose of warfarin was increased to 350% in 3 mo before reaching the lower international normalized ratio treatment window. No obvious adverse reaction occurred during the d ...[more]